Abstract:Bone and soft tissue tumors (BST) are a highly heterogeneous group largely classified by their line of differentiation, based on their resemblance to their normal counterpart in adult tissue. Yet, rendering a specific diagnosis can be challenging, primarily due to their rarity and overlapping histopathologic features or clinical presentations. Over the past few decades, seemingly histogenetic-specific gene fusions/translocations and amplifications have been discovered, aiding in a more nuanced classification, leading to well-established objective diagnostic criteria and the development of specific surrogate ancillary tests targeting these genetic aberrations (e.g., immunohistochemistry). Ironically, the same research also has revealed that some specific tumor subtypes may be the result of differing and often multiple gene fusions/translocations, but, more interestingly, identical gene fusions may be present in more than one phenotypically and biologically distinct neoplasm, sometimes with entirely different clinical behavior. Prime examples include, EWSR1::ATF1 and, less commonly, EWSR1::CREB1 gene fusions present in both clear cell sarcoma, a malignant high-grade tumor with melanocytic differentiation, and angiomatoid fibrous histiocytoma, a mesenchymal neoplasm of intermediate malignancy with a generally indolent course. Similarly, MDM2 amplification, once deemed to be pathognomonic for atypical lipomatous tumor/well differentiated and dedifferentiated liposarcoma, has been documented in a range of additional distinct tumors, including low grade osteosarcomas (e.g. low grade central and surface parosteal) and high-grade intimal sarcomas, amongst others. Such findings reinforce the importance of careful attention to morphological and clinicoradiological features and correlation with molecular testing before rendering a specific diagnosis. Future classification systems in BST neoplasms cannot be solely based on molecular events and ideally will balance morphologic features with molecular analysis. Herein, we provide a narrative literature review of the more common BST neoplasms with shared genetic events but differing demographics, morphology, immunophenotype, and clinical behavior, re-emphasizing the importance of the hematoxylin and eosin slide and the "eye" of the practicing pathologist.

Unusual Equine Tumors

Equine Melanocytic Tumors: A Narrative Review

Tumors of the Urogenital Tract

Oral and Sinonasal Tumors

The Diagnosis and Treatment for a Patient with Cancer of Unknown Primary: A Case Report.

Unusual liver tumors: spectrum of imaging findings with pathologic correlation

Uncommon Tumors of the Lung: Recently Described and Rediscovered Tumors

Equine Sarcoids—Causes, Molecular Changes, and Clinicopathologic Features: A Review

Clinical and Pathological Data of 17 Non-Epithelial Pancreatic Tumors in Cats

Imaging of the unusual pediatric 'blastomas'

Paraneoplastic Syndromes in Horses

Lymphoma & Myeloproliferative Disease

Unusual or Uncommon Histology of Gastric Cancer

Unusual Primary Neoplasms of the Adult Liver: Review of Imaging Appearances and Differential Diagnosis

Cytological Features and Mimickers of Thyroid Gland Sarcomas: A Case-Based Study

Oral T-cell-rich large B-cell lymphoma in a horse

Unusual imaging findings associated with abdominal pediatric germ cell tumors

Collection of Rare Peripheral Nerve Tumors-Insights from the German Registry

Hepatic glomus tumor, a case report and literature review

Back to the future! Selected bone and soft tissue neoplasms with shared genetic alterations but differing morphological and immunohistochemical phenotypes

Clinicopathologic and Molecular Features of Vascular Tumors in a Series of 118 Cases.